Research Design & Number of Studies - Adult
Some of the best available evidence for CBT in the treatment of SAD comes from meta-analytic studies. Seven of these are described below (most recent first).
The first meta-analysis evaluated the efficacy of internet-based CBT (iCBT) for SAD (Guo et al, 2021). The review included 20 studies (n=1743) and involved adults aged 18 to 79 years who met diagnostic criteria for SAD. iCBT was delivered over 9-12 weeks.
The second meta-analytic study evaluated the long-term outcomes of CBT on anxiety-related disorders (van Dis et al, 2020). The study included 69 randomised clinical trials with 4118 adult outpatients diagnosed with generalized anxiety disorder (GAD), obsessive compulsive disorder (OCD), panic disorder (PD), specific phobia, posttraumatic stress disorder (PTSD) or SAD. 7 studies were specific to SAD and meta-analyses for these participants were reported separately. CBT was delivered in individual, group, or internet formats.
The third meta-analysis was conducted to evaluate the effectiveness of CBT in anxiety and related-disorders (Carpenter et al, 2018). The study included 41 studies with 2835 participants (aged 18-65 years) diagnosed with acute stress disorder, GAD, OCD, PD, PTSD, or SAD. 12 studies (n=753) were specific to SAD and meta-analyses for these participants were reported separately. CBT was delivered face to face in either group or individual formats. Mean treatment duration across studies was 11.0 sessions.
The fourth meta-analysis was conducted to evaluate the effectiveness of computer/ internet delivered CBT on anxiety and depression disorders (Andrews et al, 2018). The study included 64 trials of participants (n=8279) diagnosed with major depression, PD, GAD or SAD. 11 of these trials (n=950) included participants with SAD, and meta-analysis for these participants was reported separately.
The fifth meta-analysis evaluated the effectiveness of technology-assisted interventions for social anxiety disorder (Kampmann et al, 2016). The study included 37 RCTs (n=2991). Of these, 21 trials evaluated internet delivered CBT, and meta-analysis for this was reported separately. Participants were adults (aged at least 18 years) who met diagnosis criteria for SAD.
The sixth was a systematic review and network meta-analysis conducted to evaluate the effectiveness of psychological and pharmacological interventions for SAD (Mayo-Wilson et al, 2014). Participants were adults (aged at least 18 years) who fulfilled diagnostic criteria for SAD. The study included 101 trials (n=13164 participants). Of these, 43 studies evaluated CBT delivered in individual and group formats, while 25 studies evaluated self-help interventions that were usually CBT based.
The seventh meta-analysis was conducted to determine the effectiveness of CBT in the management of anxiety disorders (Hofmann and Smits, 2008). Participants were between ages 18 and 65 years, and met the diagnostic criteria for an anxiety disorder or anxiety related disorder including PTSD, PD, OCD, acute stress disorder (ASD), GAD, and SAD. 27 studies were included in the review. Of these, 7 studies were specific to SAD, and meta-analysis for these participants was reported separately.
Outcomes Achieved - Adult
Compared to usual care, psychological or pill placebo, or wait-list control, the following outcomes were observed;
- Significantly reduced SAD symptoms/ severity at post-treatment (Guo et al, 2021; van Dis et al, 2020; Carpenter et al, 2018; Andrews et al, 2018; Kampmann et al, 2016; Mayo-Wilson et al, 2014; Hofmann and Smits, 2008) and follow-up (i.e. up to 6-12 months follow-up) (Guo et al, 2021; van Dis et al, 2020; Carpenter et al, 2018; Kampmann et al, 2016)
- Significantly reduced depression symptoms at post-treatment (Kampmann et al, 2016). Significant improvement in depression and anxiety symptoms were also reported in pooled data for all included anxiety and related disorders at post-treatment and at 6 months follow-up (Carpenter et al, 2018)
- Significantly improved quality of life at post-treatment (Kampmann et al, 2016). Significant improvement in quality of life was also reported in pooled data for all included anxiety and related disorders at post-treatment and at 6 months follow-up (Carpenter et al, 2018)